Skip to main content
. 2016 Jan 30;28(1):169–174. doi: 10.1589/jpts.28.169

Table 3. Changes in clinical outcome measures between pre- and post-treatment.

Variables Experimental group Control group
Δ FMA-LLparetic 2.00 ± 2.79 3.00 ± 4.60
ΔBBS 10.40 ± 8.25 10.80 ± 5.01
Δ6MWT (m) 93.50 ± 56.28 118.50 ± 50.40
ΔK-MBI 21.30 ± 15.13 27.90 ± 14.93

Values are mean ± standard deviation. FMA-LLparetic: paretic lower limb score of the Fugl-Meyer assessment; BBS: Berg balance test; 6MWT: 6-minute walk test; K-MBI: Korean version of the Modified Barthel Index